The global forensic technology market size was estimated at USD 13.8 billion in 2016 and is anticipated to grow at a CAGR of 12.7% throughout the forecast period. A high upsurge in the number of violent crimes across the globe is a high impact growth rendering driver of the forensic technology market. Intentional homicide, murder, rape, and robbery are the primary reasons propelling the need for forensics, thereby fueling growth. According to the United Nations Office on Drugs and Crime (UNODC), in their last study conducted in 2012, the global average of intentional homicide was reported to be 6.2 per 100,000 people. In addition, amongst all regions, the Americas accounted for the highest rate of intentional homicide followed by Africa and Asia.
Thus, an upsurge in the number of crimes has led to an increase in the number of unresolved cases, which calls for the urgent adoption of advanced technologies to clear the backlog of pending cases. The absence of concrete evidence leads to unresolved cases, which depicts a high need to adopt forensic technologies. According to research published in NCBI, one-third of murders in the U.S. are unresolved and awaiting conviction.
U.S. forensic technology market by product, 2014 - 2025 (USD Million)
The market is also predominantly driven by increasing investments by various public and private organizations for forensic research. For instance, the Debbie Smith DNA Backlog Grant Program provides funds to local as well as state governments to reduce the backlog of untested and unanalyzed DNA evidence. The primary purposes served by this grant include conducting an analysis of biological samples under applicable legal authority, improving the capacity of the state as well as local laboratories to conduct DNA analyses, and ensure streamlined analysis. In addition, the Katie Sepich Enhanced DNA Collection Act of 2012 amended the Debbie Smith Grant program to assign funds for the fiscal year 2013 to 2015 to meet costs associated with the collection of DNA samples from criminal suspects.
Furthermore, the introduction of the Debbie Smith Reauthorization Act of 2014 extended the authorization of funds until 2019. This amendment will lead to usage of up to 4% of the funds appropriated for the enhancement of capacity & infrastructure of forensic facilities. Thus, such grants are anticipated to improve existing technologies, increase the accuracy & efficiency of DNA analysis, and reduce the time & expenses involved in resolving the case, thereby creating remunerative growth prospects.
Capillary electrophoresis held the largest share in 2016. The dominant share of the segment can be attributed to the benefits offered by this technique. These benefits include increased resolution, reduced risk of cross-contamination, online detection, higher speed, minimal consumption of sample, and easy-to-use techniques.
This technique can also quantify and provide rapid profiling of anionic species found in poisons and explosives. Widespread usage of the capillary electrophoresis technique has been observed owing to its ease in preparing samples, simpler detection methods, and microsampling capabilities.
Next-Generation Sequencing (NGS) is expected to grow at a lucrative rate over the coming years. This lucrative growth rate can be attributed to the associated benefits such as its improved ability of human identification in degraded biological samples and enhanced paternity testing.
NGS also allows the generation of total human genome data and helps reduce bias &errors. Moreover, the penetration of NGS into newer applications is also expected to present lucrative opportunities. For example, Applied Biosystems Precision ID NGS System developed by Thermo Fisher Scientific was launched specifically for human identification.
Chemical analysis captured considerable share in the services segment in 2016. Chemical analysis has a wide array of applications such as toxicology studies, fire debris analysis, bloodstain pattern analysis, serology, alcohol testing, fingerprinting, and analysis of trace evidence, which is presumed to provide an upsurge to the segment.
The increasing preference of forensic experts toward chemical analysis cases of drug abuse is also one of the key growth contributing factors. For instance, a breathalyzer kit is used by most of the state patrol vehicles and police squad cars to identify alcohol intoxication.
DNA profiling is expected to exhibit lucrative growth throughout the forecast period. This growth can be attributed to its wide range of applications in body fluid identification, paternity testing, the examination of drug abuse, and the identification of disaster victims.
Moreover, growing R&D and DNA databases across the globe are predicted to drive the market over the coming years. For instance, the Department of Defense and the U.S. Department of Justice allocated funds of USD 2.5 million to develop advanced technologies that can increase the efficiency of tests.
Judicial/law enforcement captured the largest share in the application segment in 2016. Consistent efforts by government authorities across the globe to create DNA databases are serving as a key growth contributing factor. The DNA Identification Act 1994 in the U.S. provided the FBI authority to develop a national DNA database to assist in solving backlog criminal cases, which has resulted in a significant upsurge in the adoption of forensics in the administration of justice.
Moreover, the growth in judicial applications is also driven by the adoption of a wide array of other techniques that allows lab technicians to gather information from DNA samples at reduced costs and time. For instance, with the help of technologically advanced techniques, it is possible to generate DNA profiles within 90 minutes from swabs.
Biodefense & bio-surveillance is anticipated to grow at a constant CAGR over the coming years. Sudden disease outbreaks caused by naturally occurring pathogens are responsible for over 15.0 million deaths every year, which exerts a huge impact on the global economy, thereby presenting an attractive market opportunity. Furthermore, increasing the risk of terrorism through bioweapons is anticipated to fuel the segment growth.
Laboratory forensic technology accounted for the largest share of the location segment in 2016. This can be attributed to the presence of testing instruments, which are bulky in nature and designed for the testing of a large volume of samples.
In addition, the adoption of laboratory equipment by forensic experts is higher as they are relatively cheaper. Various regulations have been established to ensure a high quality of forensic laboratories for achieving results with higher accuracy, which is anticipated to provide a significant boost to the market.
The portable technology segment is predicted to grow at an exponential CAGR during the forecast period. The introduction of portable& handheld devices allows on-site operation and is largely used in the detection of alcohol and drug intoxication, especially in case of road accidents. Moreover, such portable testing devices are expected to reduce the backlog of pending criminal cases in laboratories.
In 2016, North America accounted for the largest share of over 37.0% of the market owing to the increasing rate of violent crimes across this region. There has been a significant increase in the adoption of forensics by private companies and law enforcement agencies amongst various sectors including healthcare in this region, thereby attracting a higher share. The development of sophisticated and supportive healthcare infrastructure has led to an improvement in the efficiency of forensic studies and is anticipated to boost the market.
Global forensic technology market share by region, 2016 (%)
The Asia Pacific is expected to grow at an exponential rate of 14.6% throughout the forecast period. This exponential growth can be attributed to rising investments in human identification applications across this region. In addition, an exponential rise in the number of criminal activities in emerging economies such as India and China has raised the need to adopt various technologies for DNA identification for expedited conviction.
The key players are extensively deploying strategies to sustain a highly competitive environment. Agilent Technologies, Thermo Fisher Scientific, SPEX Forensics, and LGC Limited are some of the key players. These companies usually employ strategies such as mergers & acquisitions, new product development initiatives, and geographical expansion to increase their share and sustain the competition.
For instance, in March 2017, Agilent Technologies launched a research-grade Triple Quadrupole LC/MS System. This product launch was undertaken to expand their offerings and venture into various research applications such as forensic toxicology, environmental testing, clinical research, and peptide quantitation.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2025
Revenue in USD Million and CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global forensic technology market:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Rapid DNA Analysis
Automated Liquid Handling Technology
Services Outlook (Revenue, USD Million, 2014 - 2025)
Application Outlook (Revenue, USD Million, 2014 - 2025)
Biodefense & Biosurveillance
Location Outlook (Revenue, USD Million, 2014 - 2025)
Laboratory Forensic Technology
Portable Forensic Technology
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.